Aarhus University Seal / Aarhus Universitets segl

Immunological Biotechnology


Immunological biotechnology enables the development of strategies for dissecting and manipulating molecular processes in health and disease and is a crucial approach for establishment and optimisation of tools for therapeutic intervention as well as diagnostics.

Central for our research is the molecular access to the disease and a  mechanism-driven development of biologicals at the interface of immunology, protein biochemistry, biotechnology, and chemistry. Within this concept the specific needs for patient tailored, precision medical treatment are addressed.

Specific research interests and projects primarily focus on molecular immunology in research, diagnostics and therapy:

Immune repertoires and combinatorial technologies

Immunoglobulins: isotypes, functions, targeting

Molecular allergology

Molecular recognition in health and disease

Antibody technologies for diagnostics and intervention


- Nanna, Josephine, Coline and Michaela present at the EAACI conference (Jul 20)

- Postdoc position open in development of therapeutic  biomolecules within allergy research (link)

- Position paper of the WHO/IUIS allergen nomenclature subcommittee on the nature and clinical impact of "Carbohydrate Epitopes Currently Recognized as Targets for IgE Antibodies" published in Allergy (Mar 21)

- Welcome to Mona Pourjafar as guest PhD and Mathias and Magnus as bachelor students (Jan 21)

- Congratulation to Maria and Malene for their successful master examination (Jan 21)

- Welcome to Kristina Byskov as laboratory scientist (Oct 20)

- Welcome to Maria, Malene and Mike for master projects, Frederikke for an R&D project and Michaela for an internship.

- Welcome to Josephine Baunvig Aagaard starting her PhD project in the group, and Pernille Madsen for an intern project (Aug 20)

- New publication on diagnostic and therapeutic implications of a major venom allergen  (Jun 20)

- PhD position in protein biotechnology/allergy research open! (Apr 20)

- Now published: The structure of intact IgE and the mechanism of ligelizumab revealed by EM (Feb 20)

- New manuscript on B cell epitopes of insect venom allergens published (Jan 20)

- Welcome to Coline Sivelle as new postdoc in the group (Jan 20)

- Novo Nordisc Foundation funds new project on inhibition of IgE reactivity (Dec. 19)

- Industrial PhD with ALK funded. (Dec. 19)

- New project on the inhibition of hypersensitivity funded by the Independent Research Fund Denmark- Medical Sciences (May 19)